RadiationtherapyTaxanesVenlafaxineIntermediate(11-25)AromataseinhibitorsExemestaneLoperamideprophylaxis1yearAnthracyclinesCapecitabinePertuzumabOlaparib2yearsLVEFmonitoringTNBC10yearsTamoxifenTDM-1(Ado-trastuzumabemtansine)AbemaciclibPembrolizumabPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)TC (docetaxel /cyclophosphamide)ChemoendocrinetherapyEverymonthRadiationtherapyTaxanesVenlafaxineIntermediate(11-25)AromataseinhibitorsExemestaneLoperamideprophylaxis1yearAnthracyclinesCapecitabinePertuzumabOlaparib2yearsLVEFmonitoringTNBC10yearsTamoxifenTDM-1(Ado-trastuzumabemtansine)AbemaciclibPembrolizumabPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)TC (docetaxel /cyclophosphamide)ChemoendocrinetherapyEverymonth

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Radiation therapy
  2. Taxanes
  3. Venlafaxine
  4. Intermediate (11-25)
  5. Aromatase inhibitors
  6. Exemestane
  7. Loperamide prophylaxis
  8. 1 year
  9. Anthracyclines
  10. Capecitabine
  11. Pertuzumab
  12. Olaparib
  13. 2 years
  14. LVEF monitoring
  15. TNBC
  16. 10 years
  17. Tamoxifen
  18. TDM-1 (Ado-trastuzumab emtansine)
  19. Abemaciclib
  20. Pembrolizumab
  21. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  22. TC (docetaxel / cyclophosphamide)
  23. Chemoendocrine therapy
  24. Every month